Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
about
Drug-eluting stents versus bare metal stents for angina or acute coronary syndromesDrug-eluting stents versus bare metal stents for angina or acute coronary syndromesLong-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysisMultifaceted prospects of nanocomposites for cardiovascular grafts and stentsThe safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart diseaseComparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled TrialsSurvival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual?Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program.Nanomedicine for the reduction of the thrombogenicity of stent coatings.Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial.A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical programCoronary Aneurysm Formation After Bioresorbable Vascular Scaffold Implantation Resulting in Acute Myocardial InfarctionClinical Implication of Optical Coherence Tomography-Based Neoatherosclerosis.Bayesian design of noninferiority trials for medical devices using historical data.Drug-eluting stentsSmooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stabilityEfficacy and safety of drug-eluting stents in the real world: 8-year follow-up.Second- versus first-generation drug-eluting stents for diabetic patients: a meta-analysis.Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approachEffectiveness of drug-eluting stents versus bare-metal stents in large coronary arteries in patients with acute myocardial infarction.Effect of imatinib mesylate and rapamycin on the preformed intimal hyperplasia in rat carotid injury model.Clinical and angiographic outcomes after intracoronary bare-metal stenting.Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.Clinical performance of biodegradable versus permanent polymer drug-eluting stents: A meta-analysis of randomized clinical trials at long-term follow-up.Analysis of potential cost-savings after introduction of drug-eluting balloon angioplasty for in-stent restenosis or small vessel diseaseSirolimus-eluting dextran and polyglutamic acid hybrid coatings on AZ31 for stent applications.The Food and Drug Administration and pragmatic clinical trials of marketed medical products.Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.New stent design for use in small coronary arteries during percutaneous coronary interventionThe power prior: theory and applicationsDrug eluting stents: an updated meta-analysis of randomised controlled trialsRestenosis related to percutaneous coronary intervention has been solved?Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent.An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial program.Off-label use: an industry perspective on expanding use beyond approved indications.Cypher versus Taxus: the stent war.New developments in coronary stent technology.Adjunctive pharmacotherapy for coronary interventions-time to read the writing on the wall.Promoting vascular regeneration as an alternative to conventional angioplasty-based intervention.Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial
P2860
Q24186681-5F746BC3-4218-45FD-A8D1-E8148B349E01Q24235466-D0A4862B-E04A-4B00-AAE8-53B2529A3AB6Q26767320-C4E019F2-0CB9-48ED-AE0C-21F8E6C5FDB4Q28081589-20402054-3B96-47E2-A05E-881C3C888C40Q28200757-47A90B4D-7B01-4272-9A9B-ABC521806EEDQ28551554-7F8A425A-F945-4272-9107-46FAF541B07AQ33553921-3E7AE59C-6DC1-4E2E-8BAA-ED653AAF8929Q33571243-505F07C4-931C-4AF8-9F05-4737DA69682EQ33576893-0AF20A3E-6723-4AEE-B925-539949B7CFD1Q33661362-30917829-1BB1-4244-BABB-CF323F21AEDDQ33677854-80F0D15B-A1E5-4ADF-AC36-944860BD2642Q33718126-8AB33F67-F629-451F-8B6D-DBB553C3E09DQ33770283-9A7EDCD3-BB8A-4854-AF81-D01D03499EF5Q33833003-FEF3D939-FA37-4627-9DD8-8AC1904EA3BEQ34091036-47DC4BFD-D861-4A9F-B9A4-9C72F64CBF32Q34134537-75A9F41A-DCBA-4732-AE72-299D1065E653Q34319885-D7450BFF-3D6B-4A0B-9FDE-E8ABA125706EQ34662245-DF21DEE9-3DF3-478D-A800-9EAE9BDA7B66Q34731151-C79881B9-2B7D-4BDA-90C0-6DD856751DDEQ34753360-4EBED226-D1F8-4D9F-8608-C9ED5F881557Q35139482-733FE13E-2B2B-484C-A32D-68AE33756559Q35146546-15ED2DFD-7D7A-460E-A906-DD13ACF8EEBCQ35354402-D2020AF7-A980-4D49-91D0-B534554959F6Q35579187-F9C42AF3-7877-4025-AE9B-3D42D659AE66Q35670480-0AF5FB8D-446D-4446-BAFE-786FE5829AAAQ35707420-A15AB50F-366C-453E-9A6A-01E47DCB22F6Q36117819-4C3A9EE0-88E5-445B-88E0-3C703F30839BQ36154232-CC2E4E92-4EE5-4CA9-8AC6-4D3AC1563A55Q36160441-06A19BA8-24CA-4771-B050-4FEB8F540F0EQ36225762-E636672A-9657-4ECC-B1C8-7F1289CF5311Q36282710-63184721-9D2B-4282-88C5-90C7719550B2Q36486769-61CB419E-2A44-40A7-BD22-25975675E463Q36614116-1AC7762B-CDBE-4CFF-B87D-8D057103BC5CQ36614126-3C158E15-8E61-4013-B094-5F33A71AE0BFQ36614131-641D08D6-A9B9-432A-8932-A4A108CAC0A5Q36654328-8D8A6DC7-D66A-452C-9D45-A5CBA196F708Q36654375-CE564384-FC48-411D-81C2-F1B55BCA1CB8Q36680683-0581277D-A420-412A-819C-0CADFC22857EQ36684479-6A4CC066-4B58-44D6-8364-D9C22255E8C0Q36687927-2F799C70-7015-4456-993D-A6D94658BCB7
P2860
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Comparison of a polymer-based ...... a randomized controlled trial.
@en
Comparison of a polymer-based ...... a randomized controlled trial.
@nl
type
label
Comparison of a polymer-based ...... a randomized controlled trial.
@en
Comparison of a polymer-based ...... a randomized controlled trial.
@nl
prefLabel
Comparison of a polymer-based ...... a randomized controlled trial.
@en
Comparison of a polymer-based ...... a randomized controlled trial.
@nl
P2093
P356
P1476
Comparison of a polymer-based ...... a randomized controlled trial.
@en
P2093
Charles D O'Shaughnessy
Douglas Spriggs
Gregg W Stone
J Tift Mann
Joel D Greenberg
Joerg Koglin
Louis Cannon
Mary E Russell
Patrick Hall
Samuel DeMaio
P304
P356
10.1001/JAMA.294.10.1215
P407
P577
2005-09-01T00:00:00Z